In this study we showed that mutation and loss of TSC1 in bladder cancer cells reduced the accumulation of Hsp90 inhibitors in these cells and decreased cell sensitivity to Hsp90 inhibitors. Here, TSC1 is linked to urinary bladder carcinoma.